Cardiac injury as late tOXlcity of mediastinal radiation therapy for Hodgkin's disease patients

Haematologica

Volumn 81, Issue 2, 1996, Pages 132-137

  Zinzani, Pier Luigi ^a,b   Gherlinzoni, Filippo ^a   Piovaccari, Giancarlo ^a   Frezza, Giovanni ^a   Bendandi, Maurizio ^a   Ferretti, Rossella M ^a   Barbieri, Enza ^a   Fiacchini, Mauro ^a   Babini, Lucio ^a   Magnani, Bruno ^a   Tura, Sante ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Ist Ematologia Oncol Medica L A   (Italy)

Author keywords

Hodgkin's disease; Late cardiac toxicity; Mediastinal irradiation

Indexed keywords

ADOLESCENT; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CANCER RADIOTHERAPY; CARDIOTOXICITY; ECHOCARDIOGRAPHY; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; RADIATION INJURY; RADIOISOTOPE VENTRICULOGRAPHY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; FEMALE; HEART; HODGKIN DISEASE; HUMANS; MALE; MEDIASTINUM; RADIATION INJURIES; RISK ASSESSMENT;

EID: 0030321765     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. De Vita VTJr, Simon RM, Hubbard SM, et al. Curability of advanced Hodgkin's disease with chemotherapy: long-term follow-up of MOPP treated patients at National Cancer Institute. Ann Intern Med 1980; 92:587-95.
2. De Vita VTJr, Hubbard SM, Longo DL. Treatment of Hodgkin's disease. J Natl Cancer lnst 1990; 10:19-28.
3. Mazza P, Bocchia M, Zinzani PL, et al. Hodgkin's disease: summary of twenty years' experience. Haematologica 1992; 77-487-93.
4. Zinzani PL, Barbieri E, Gherlinzoni F, et al. Radiotherapy in early stage Hodgkin's disease. Leuk Lymphoma 1994; 13:285-9.
5. Applefeld MM, Wiernik PH. Cardiac disease after radiation therapy for Hodgkin's disease: analysis of 48 patients. Am J Cardiol 1983; 51:1679-881.
6. Pohjola-Sintonen S, Totterman KJ, Salmo M, Siltanen P. Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's disease. Cancer 1987; 60:31-7.
7. Cosset JM, Henry-Amar M, Girinski T, Malaise E, Dupoy N, Dutreix J. Late toxicity of radiotherapy in Hodgkin's disease. Acta Oncologica 1988; 27:123-9.
8. Applefeld MM, Cole JF, Pollock SH, et al. The late appearance of chronic percardial disease in patients treated by radiotherapy for Hodgkin's disease. Ann Intern Med 1981; 94:338-41.
9. Cosset JM, Henry-Amar M, Pellae-Cosset B, et al. Pericarditis and myocardial infarctions after Hodgkin's disease therapy. Int J Radiation Oncol Biol Phys 1991; 21:447-9.
10. Tarbell NJ, Thompson L, Mauch P. Thoracic irradiation in Hodgkin's disease: disease control and long-term complications. Int J Radiation Oncol Biol Phys 1989; 18:275-81.
11. Savage DE, Constine LS, Schwartz RG, Rubin P. Radiation effects on left ventricular function and myocardial perfusion in long term survivors of Hodgkin's disease. Int J Radiation Oncol Biol Phys 1990; 19:721-7.
12. Henry-Amar M, Hayat M, Meerwaldt JH, et al. Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. Int J Radiation Oncol Biol Phys 1990; 19:1155-7.
13. Boivin JF, Hutchison GB, Lubin JH, Mauch P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 1992; 69:1241-7.
14. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents, J Clin Oncol 1993; 11:1208-15.
15. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993; 270:1949-55.
16. Glanzmann C, Huguenin P, Lutolf UM, Maire R, Jenni R, Gumppeenberg V. Radiotherapy Oncology 1994; 30:43-54.
17. Joensuu H. Acute myocardial infarction after heart irradiation in young patients with Hodgkin's disease. Chest 1989; 56: 943-6.
18. Mill WB, Baglan RJ, Kurichety P, Prasead S, Lee JY, Moller R. Symptomatic radiation induced pericarditis in Hodgkin's disease. Int J Radiation Oncol Biol Phys 1984; 10:2061-5.
19. Gustavsson A, Eskilsson T, Landberg T, et al. Late cardiac effects after mantle radiotherapy in patients with Hodgkin's disease. Ann Oncol 1990; 1:355-63.
20. Pierga JY, Manoury C, Valette H, et al. Follow-up thallium-201 scintigraphy after mantle field radiotherapy for Hodgkin's disease. Int J Radiation Oncol Biol Phys 1993; 25: 871-6.
21. Kreuser ED, Voller H, Behles C, et al. Evaluation of late cardiotoxicity with pulsed doppler echocardiography in patients treated for Hodgkin's disease. Br J Haematol 1993; 84:615-22.
22. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the committee on Hodgkin's disease staging classifications. Cancer Res 1971; 31:1860-1.
23. De Vita VTJr, Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 1970; 73:881-95.
24. Kaplan REL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-8.
25. Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis 1958; 8: 699-713.
26. Donaldson SS. Hodgkin's disease in children. Semin Oncol 1990; 17:736-48.
27. Horning SJ, Hoppe RT, Hancock SL, Rosenberg SA. Vinblastine, bleomycin, and methotrexate: an effective adjuvant in favorable Hodgkin's disease. J Clin Oncol 1988; 6:1822-31.
28. Rosenberg SA. Reducing the toxicity of the combined modality therapy of favourable stage Hodgkin's disease. Eur J Cancer 1992; 28:1379-80.
29. Levis A, Depaoli L, Urgesi A, et al. Probability of cure in elderly patients affected by Hodgkin's disease. Haematologica 1994; 79:46-54.